LFB SA Board of Directors

Composition of the LFB SA Board of Directors, chaired by Denis DELVAL, chairman and CEO of LFB SA.

French government representative:

Jérémie GUE

Head of the Legal Division at the Government Investments Agency (APE)

Members of the Board appointed by the General Assembly, proposed by French State:

Pascale AUGÉ

Chair of the Executive Board, INSERM TRANSFERT SA

François AUVIGNE

Inspector of Taxes, IFG, Ministry of Action and Public Accounts

Denis DELVAL

CEO of LFB

Corinne FAU

Member of the Board and Director of Finance, Purchasing and Insurance for ENEDIS

Laurence MÉGARD

Deputy Director in sectors of Health, Fashion and Luxury Industries and Consumer Goods, DGE

Independent members of the Board appointed by the General Assembly:

Gilles BRISSON

Member of the Supervisory Board of Innate Pharma (SA) and of the Supervisory Board of Financière Verdi III (SAS)

Eric DRAPÉ

Executive VP TEVA PHARMACEUTICALS Ltd , Member of the Board Teva Takeda Pharma Ltd (Japan, SAS)

Members of the Board representing employees:

Dominique SAINT PICQ

Change Control Coordinator – LFB BIOMEDICAMENTS

Jérôme WACRENIER

IT industrial engineer – Arras plant - LFB BIOMEDICAMENTS

Financial and Economic auditors:

François GUILLON

Auditing PRICEWATERHOUSECOOPERS firm

Laurent BRUN

Cabinet CAILLIAU DEDOUIT and associated

Guests

Maurice-Pierre PLANEL

Government auditor, Général Deputy Director of Health

Marc GAZAVE

Economic and Financial Controller